Latest Commercialisation News

Page 62 of 117
Tissue Repair Limited reports steady progress in its Phase 3 clinical trials for TR987® despite patient recruitment hurdles, while TR Pro+® sales surge and new distribution deals pave the way for international growth.
Ada Torres
Ada Torres
31 July 2025
Clarity Pharmaceuticals has bolstered its cash reserves to approximately $288 million following a $203 million institutional placement, while reporting significant clinical progress across multiple copper-based radiopharmaceutical trials targeting prostate cancer and neuroendocrine tumours.
Ada Torres
Ada Torres
31 July 2025
Blue Star Helium has completed flow testing at its Mula well in Colorado, revealing robust gas flow rates and a helium concentration above regional norms, bolstering the asset’s commercial promise.
Maxwell Dee
Maxwell Dee
31 July 2025
Conrad Asia Energy has advanced its position in Indonesia’s natural gas sector with a major gas sales agreement and increased ownership in the Duyung PSC. The company also completed a A$9 million capital raise to fund upcoming development milestones.
Maxwell Dee
Maxwell Dee
31 July 2025
Decidr AI Industries reported an 82% revenue jump in its AI platform during Q4 FY25, launched AI Mentors with The Growth Faculty, and divested its 13Seeds business to sharpen focus on AI innovation.
Sophie Babbage
Sophie Babbage
31 July 2025
Micro-X has landed a significant supply agreement with a top US healthcare provider for its Rover Plus mobile X-ray units, while progressing clinical trials and development milestones for its innovative CT imaging products.
Victor Sage
Victor Sage
31 July 2025
Volt Group reported a 15% decline in Q2 FY25 revenue due to customer order timing delays but secured new Wescone orders pointing to a strong Q3 recovery. Meanwhile, EcoQuip and ATEN projects advanced with promising demonstrations and feasibility studies.
Victor Sage
Victor Sage
31 July 2025
Rhythm Biosciences has successfully validated its ColoSTAT® colorectal cancer test, secured its first strategic partnership for Genetype, and secured $1 million in non-dilutive funding, setting the stage for a transformative FY26.
Ada Torres
Ada Torres
31 July 2025
Carnegie Clean Energy has made significant strides in advancing its wave energy technologies, signing key MOUs and achieving critical milestones in the ACHIEVE Programme during the June 2025 quarter.
Victor Sage
Victor Sage
31 July 2025
Acrux Limited has secured a decade-long licensing agreement with Servacure to commercialise its FDA-approved Dapsone 5% Gel in Saudi Arabia, marking a strategic step in its global expansion.
Victor Sage
Victor Sage
31 July 2025
Lithium Universe Limited has secured global rights to a breakthrough solar panel recycling technology that promises to unlock vast reserves of critical minerals, while advancing its Québec lithium refinery with robust financials and strategic partnerships.
Maxwell Dee
Maxwell Dee
31 July 2025
Nyrada reports successful completion of five cohorts in its Phase I trial of Xolatryp with no safety concerns, alongside compelling preclinical neuro- and cardioprotective data. A Phase IIa trial targeting heart attack patients is slated for early 2026.
Ada Torres
Ada Torres
31 July 2025